Earlier, Stanford Group downgradeed Ceradyne (Nasdaq: CRDN) from Hold to Sell, citing long-term concerns ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE